Di Wu
PR China
Changsha, Puerto Rico
Changsha, Puerto Rico
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
CRISPR/Cas9-mediated PD-1 attenuation enhances tumor infiltrating lymphocyte-based adoptive cellular therapy in humanized-PDX model of hepatocellular carcinoma.
Journal: Translational oncology
Published: June 02, 2025
In vivo mechanism of the interaction between trimethylamine lyase expression and glycolytic pathways.
Journal: Food & function
Published: November 28, 2024
Integrated multi-omics demonstrates enhanced antitumor efficacy of donafenib combined with FADS2 inhibition in hepatocellular carcinoma.
Journal: Translational oncology
Published: June 12, 2024
SLC25A19 is a novel prognostic biomarker related to immune invasion and ferroptosis in HCC.
Journal: International immunopharmacology
Published: April 12, 2024
The first familial NSD2 cases with a novel variant in a Chinese father and daughter with atypical WHS facial features and a 7.5-year follow-up of growth hormone therapy.
Journal: BMC medical genomics
Published: December 24, 2019
Sulphonate functionalized covalent organic framework-based magnetic sorbent for effective solid phase extraction and determination of fluoroquinolones.
Journal: Journal of chromatography. A
Published: July 23, 2019
Physcion induces apoptosis in hepatocellular carcinoma by modulating miR-370.
Journal: American journal of cancer research
Published: October 24, 2016
Zinc finger protein 191 inhibits hepatocellular carcinoma metastasis through discs large 1-mediated yes-associated protein inactivation.
Journal: Hepatology (Baltimore, Md.)
Published: December 06, 2015
Showing 1-9 of 9
Last Updated: 09/26/2026